Evidence map›Paper›PMID 35898460›Full record

ArticleFrontiers in endocrinology2022

Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle.

Sheng Li, Milena Schönke, Jacobus C Buurstede, Tijmen J A Moll, Max Gentenaar, Maaike Schilperoort, Jenny A Visser, Kasiphak Kaikaew, Davy van de Vijver, Tooba Abbassi-Daloii and 5 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Sex-specific phosphoproteome responses to calorie restriction and insulin in skeletal muscle from older rats.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Sheng LiDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Milena SchönkeDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Jacobus C BuurstedeDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Tijmen J A MollDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Max GentenaarDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Maaike SchilperoortDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Jenny A VisserDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Kasiphak KaikaewDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Davy van de VijverDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Tooba Abbassi-DaloiiDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Vered RazDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Annemieke Aartsma-RusDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Maaike van PuttenDepartment of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Onno C MeijerDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Jan KroonDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
Leiden University Medical Center · NLErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscle atrophy is common in patients with increased glucocorticoid exposure. Glucocorticoid effects are often sex-specific, and while different glucocorticoid responses between male and female subjects are reported, it is unclear why this is. In this study, we evaluated the effects of corticosterone and synthetic glucocorticoid treatment on muscle atrophy in male and female mice. We found that corticosterone treatment reduced grip strength in female mice only, whereas muscle mass was reduced in both sexes. Skeletal muscle transcriptional responses to corticosterone treatment were more pronounced and widespread in male mice. Synthetic glucocorticoid treatment reduced grip strength in both sexes, while female mice were more sensitive to muscle atrophy than male mice. To evaluate the role of androgens, chemically-castrated male mice were treated with synthetic glucocorticoids. We observed additively reduced muscle mass, but did not observe any interaction effects. Although sex differences in glucocorticoid responses in skeletal muscle are partly influenced by androgen signaling, further studies are warranted to fully delineate the underlying mechanisms.

Indexed as

CorticosteroneGlucocorticoidsAndrogensAnimalsFemaleHumansMaleMiceMuscle, SkeletalMuscular AtrophySex CharacteristicsAndrogensCorticosteroneGlucocorticoidsandrogenbetamethasonecorticosteroneglucocorticoidsmuscle atrophy

Identifiers

PMID35898460
PMCPMC9309696
OpenAlexW4285007392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.